Subcutaneous and intrahepatic growth of human hepatoblastoma in immunodeficient mice

Journal of Hepatology

Volumn 45, Issue 3, 2006, Pages 377-386

  Schnater, J Marco ^a,b,c   Bruder, Elisabeth ^d   Bertschin, Sibylle ^a   Woodtli, Thomas ^a   de Theije, Chiel ^e   Pietsch, Torsten ^b   Aronson, Daniel C ^c   von Schweinitz, Dietrich ^a   Lamers, Wouter H ^e   Köhler, Eleonore S ^a,e  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d UNIVERSITY OF BONN   (Germany)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Hepatoblastoma mouse model

Indexed keywords

ALPHA FETOPROTEIN; BETA CATENIN; BIOLOGICAL MARKER; CARBAMATE KINASE; CASPASE 3; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYTOKERATIN 18; CYTOKERATIN 19; CYTOKERATIN 7;

ABDOMINAL TUMOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BIOLOGICAL MONITORING; BLOOD ANALYSIS; CANCER CELL CULTURE; CANCER GRAFT; CANCER MODEL; CELL STRAIN HEPG2; CHILDHOOD CANCER; CONTROLLED STUDY; EXPERIMENTAL NEOPLASM; FEMALE; HEPATOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE DEFICIENCY; LIVER CELL; LIVER CELL CARCINOMA; LIVER GRAFT; LIVER TUMOR; MALE; MOUSE STRAIN; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; SKIN TUMOR; SPLEEN CANCER; TUMOR GROWTH; TUMOR VOLUME; VISCERAL METASTASIS;

ALPHA-FETOPROTEINS; ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; HEPATOBLASTOMA; HUMANS; LIVER NEOPLASMS; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; SPLENIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 33746572095     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2006.03.018     Document Type: Article

References (48)

1. Vos A. Primary liver tumours in children. Eur J Surg Oncol 21 (1995) 101-105
2. Perilongo G., and Shafford E.A. Liver tumours. Eur J Cancer 35 (1999) 953-958 [discussion 8-9]
3. Pritchard J., da Cunha A., Cornbleet M.A., and Carter C.J. Alpha feta (alpha FP) monitoring of response to adriamycin in hepatoblastoma. J Pediatr Surg 17 (1982) 429-430
4. von Schweinitz D., Hecker H., Schmidt-von-Arndt G., and Harms D. Prognostic factors and staging systems in childhood hepatoblastoma. Int J Cancer 74 (1997) 593-599
5. Pritchard J., Brown J., Shafford E., Perilongo G., Brock P., Dicks-Mireaux C., et al. Cisplatin, doxorubicin, and delayed surgery for childhood hepatoblastoma: a successful approach - results of the first prospective study of the International Society of Pediatric Oncology. J Clin Oncol 18 (2000) 3819-3828
6. Ortega J.A., Douglass E.C., Feusner J.H., Reynolds M., Quinn J.J., Finegold M.J., et al. Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: a report from the Children's Cancer Group and the Pediatric Oncology Group. J Clin Oncol 18 (2000) 2665-2675
7. Schnater J.M., Aronson D.C., Plaschkes J., Perilongo G., Brown J., Otte J.B., et al. Surgical view of the treatment of patients with hepatoblastoma: results from the first prospective trial of the International Society of Pediatric Oncology Liver Tumor Study Group. Cancer 94 (2002) 1111-1120
8. Leveille-Webster C.R., and Arias I.A. Establishment and serial quantification of intrahepatic xenografts of human hepatocellular carcinoma in severe combined immunodeficiency mice, and development of therapeutic strategies to overcome multidrug resistance. Clin Cancer Res 2 (1996) 695-706
9. Miyoshi E., Noda K., Ko J.H., Ekuni A., Kitada T., Uozumi N., et al. Overexpression of alpha1-6 fucosyltransferase in hepatoma cells suppresses intrahepatic metastasis after splenic injection in athymic mice. Cancer Res 59 (1999) 2237-2243
10. Hata Y., Uchino J., Sato K., Sasaki F., Une Y., Naito H., et al. Establishment of an experimental model of human hepatoblastoma. Cancer 50 (1982) 97-101
11. Suzuki T., Watanabe K., Hirota M., Iwafuchi M., Ono T., Aoyagi Y., and Ito S. Establishment of a human hepatoblastoma model in athymic nude mice. Producibility of fatty acid-binding protein, alpha-fetoprotein, and alpha 1-acid glycoprotein. Acta Pathol Jpn 42 (1992) 255-261
12. Desdouets C., Fabre M., Gauthier F., Brechot C., and Sobczak-Thepot J. Proliferation and differentiation of a human hepatoblastoma transplanted in the Nude mouse. J Hepatol 23 (1995) 569-577
13. Fuchs J., Schmidt D., Pietsch T., Miller K., and von Schweinitz D. Successful transplantation of human hepatoblastoma into immunodeficient mice. J Pediatr Surg 31 (1996) 1241-1246
14. Fuchs J., Wenderoth M., von Schweinitz D., Haindl J., and Leuschner I. Comparative activity of cisplatin, ifosfamide, doxorubicin, carboplatin, and etoposide in heterotransplanted hepatoblastoma. Cancer 83 (1998) 2400-2407
15. Fuchs J., Gratz K.F., Habild G., Gielow P., von Schweinitz D., and Baum R.P. Immunoscintigraphy of xenotransplanted hepatoblastoma with iodine 131-labeled anti-alpha-fetoprotein monoclonal antibody. J Pediatr Surg 34 (1999) 1378-1384
16. Pietsch T., Fonatsch C., Albrecht S., Maschek H., Wolf H.K., and von Schweinitz D. Characterization of the continuous cell line HepT1 derived from a human hepatoblastoma. Lab Invest 74 (1996) 809-818
17. von Schweinitz D., Faundez A., Teichmann B., Birnbaum T., Koch A., Hecker H., et al. Hepatocyte growth-factor-scatter factor can stimulate post-operative tumor-cell proliferation in childhood hepatoblastoma. Int J Cancer 85 (2000) 151-159
18. Doi I. Establishment of a cell line and its clonal sublines from a patient with hepatoblastoma. Gann 67 (1976) 1-10
19. Aden D.P., Fogel A., Plotkin S., Damjanov I., and Knowles B.B. Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature 282 (1979) 615-616
20. Flanagan S.P. 'Nude', a new hairless gene with pleiotropic effects in the mouse. Genet Res 8 (1966) 295-309
21. Segre J.A., Nemhauser J.L., Taylor B.A., Nadeau J.H., and Lander E.S. Positional cloning of the nude locus: genetic, physical, and transcription maps of the region and mutations in the mouse and rat. Genomics 28 (1995) 549-559
22. Fogh J., Fogh J.M., and Orfeo T. One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J Natl Cancer Inst 59 (1977) 221-226
23. Carlsson G., Gullberg B., and Hafstrom L. Estimation of liver tumor volume using different formulas - an experimental study in rats. J Cancer Res Clin Oncol 105 (1983) 20-23
24. Charles R., De Graaf A., Lamers W.H., and Moorman A.F. Control of the changes in rat-liver carbamoyl-phosphate synthase (ammonia) protein levels during ontogenesis: evidence for a perinatal change in immunoreactivity of the enzyme. Mech Ageing Dev 22 (1983) 193-203
25. Dunsford H.A., Karnasuta C., Hunt J.M., and Sell S. Different lineages of chemically induced hepatocellular carcinoma in rats defined by monoclonal antibodies. Cancer Res 49 (1989) 4894-4900
26. Duan W.R., Garner D.S., Williams S.D., Funckes-Shippy C.L., Spath I.S., and Blomme E.A. Comparison of immunohistochemistry for activated caspase-3 and cleaved cytokeratin 18 with the TUNEL method for quantification of apoptosis in histological sections of PC-3 subcutaneous xenografts. J Pathol 199 (2003) 221-228
27. Niwa Y., Matsumura M., Shiratori Y., Imamura M., Kato N., Shiina S., et al. Quantitation of alpha-fetoprotein and albumin messenger RNA in human hepatocellular carcinoma. Hepatology 23 (1996) 1384-1392
28. Gaasbeek Janzen J.W., Gebhardt R., ten Voorde G.H., Lamers W.H., Charles R., and Moorman A.F. Heterogeneous distribution of glutamine synthetase during rat liver development. J Histochem Cytochem 35 (1987) 49-54
29. Gebhardt R., and Mecke D. Heterogeneous distribution of glutamine synthetase among rat liver parenchymal cells in situ and in primary culture. EMBO J 2 (1983) 567-570
30. Ruck P., Xiao J.C., and Kaiserling E. Small epithelial cells and the histogenesis of hepatoblastoma. Electron microscopic, immunoelectron microscopic, and immunohistochemical findings. Am J Pathol 148 (1996) 321-329
31. Pezzella F., Turley H., Kuzu I., Tungekar M.F., Dunnill M.S., Pierce C.B., et al. bcl-2 protein in non-small-cell lung carcinoma. N Engl J Med 329 (1993) 690-694
32. Ishak KG, Goodman ZD, Stocker JT. Hepatoblastoma. Tumors of the liver and intrahepatic bile ducts. Armed Forces Institute of Pathology: Washington, DC, 2001; pp 159-184.
33. Matsuura S., Aishima S., Taguchi K., Asayama Y., Terashi T., Honda H., et al. 'Scirrhous' type hepatocellular carcinomas: a special reference to expression of cytokeratin 7 and hepatocyte paraffin 1. Histopathology 47 (2005) 382-390
34. Ain J.F., Gouillat C., Bertrand S., Fourel I., Guillaud M., Saguier G., et al. Human hepatocellular carcinoma transplanted in nude mice: a relevant experimental model to assess tumoral destruction by alcoholization. J Surg Res 57 (1994) 366-372
35. Labonte P., Kadhim S., Bowlin T., and Mounir S. Inhibition of tumor growth with doxorubicin in a new orthotopically implanted human hepatocellular carcinoma model. Hepatol Res 18 (2000) 72-85
36. Ohashi K., Marion P.L., Nakai H., Meuse L., Cullen J.M., Bordier B.B., et al. Sustained survival of human hepatocytes in mice: a model for in vivo infection with human hepatitis B and hepatitis delta viruses. Nat Med 6 (2000) 327-331
37. Eriksson T., Frisk T., Gray S.G., von Schweinitz D., Pietsch T., Larsson C., et al. Methylation changes in the human IGF2 p3 promoter parallel IGF2 expression in the primary tumor, established cell line, and xenograft of a human hepatoblastoma. Exp Cell Res 270 (2001) 88-95
38. Asada N., Tanaka Y., Hayashido Y., Toratani S., Kan M., Kitamoto M., et al. Expression of fibroblast growth factor receptor genes in human hepatoma-derived cell lines. In Vitro Cell Dev Biol Anim 39 (2003) 321-328
39. Monga S.P., Mars W.M., Pediaditakis P., Bell A., Mule K., Bowen W.C., et al. Hepatocyte growth factor induces Wnt-independent nuclear translocation of beta-catenin after Met-beta-catenin dissociation in hepatocytes. Cancer Res 62 (2002) 2064-2071
40. Dandri M., Burda M.R., Torok E., Pollok J.M., Iwanska A., Sommer G., et al. Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus. Hepatology 33 (2001) 981-988
41. Tateno C., Yoshizane Y., Saito N., Kataoka M., Utoh R., Yamasaki C., et al. Near completely humanized liver in mice shows human-type metabolic responses to drugs. Am J Pathol 165 (2004) 901-912
42. Meuleman P., Libbrecht L., De Vos R., de Hemptinne B., Gevaert K., Vandekerckhove J., et al. Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera. Hepatology 41 (2005) 847-856
43. Mahieu-Caputo D., Allain J.E., Branger J., Coulomb A., Delgado J.P., Andreoletti M., et al. Repopulation of athymic mouse liver by cryopreserved early human fetal hepatoblasts. Hum Gene Ther 15 (2004) 1219-1228
44. Paku S., Dezso K., Kopper L., and Nagy P. Immunohistochemical analysis of cytokeratin 7 expression in resting and proliferating biliary structures of rat liver. Hepatology 42 (2005) 863-870
45. Schnater J.M., Kohler S.E., Lamers W.H., von Schweinitz D., and Aronson D.C. Where do we stand with hepatoblastoma? A review. Cancer 98 (2003) 668-678
46. Saad R.S., Luckasevic T.M., Noga C.M., Johnson D.R., Silverman J.F., and Liu Y.L. Diagnostic value of HepPar1, pCEA, CD10, and CD34 expression in separating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration cytology. Diagn Cytopathol 30 (2004) 1-6
47. Ruck P., Xiao J.C., Pietsch T., Von Schweinitz D., and Kaiserling E. Hepatic stem-like cells in hepatoblastoma: expression of cytokeratin 7, albumin and oval cell associated antigens detected by OV-1 and OV-6. Histopathology 31 (1997) 324-329
48. Zimmermann A. Hepatoblastoma with cholangioblastic features ('cholangioblastic hepatoblastoma') and other liver tumors with bimodal differentiation in young patients. Med Pediatr Oncol 39 (2002) 487-491